Growth of ovarian‐carcinoma cell lines at physiological folate concentration: Effect on folate‐binding protein expression in vitro and in vivo
- 3 November 1995
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 63 (3) , 395-401
- https://doi.org/10.1002/ijc.2910630316
Abstract
Ovarian-carcinoma cell lines (OVCAR3, IGROVI, OVCA432, SW626 and SKOV3), grown in standard medium containing supra-physiological (2.3 μM) folate concentration, display different levels of reactivity with the anti-folate-binding-protein (FBP) monoclonal antibody MOv18, which recognizes the α-iso-form of the protein. Gel-filtration and absorption experiments indicated that on IGROVI cells this molecule accounts for all folic-acid binding at nanomolar concentrations. The aim of the study was to investigate the effect of extracellular folate levels on cells adapted to grow in medium containing physiological folate concentration (20 n M). By the ternary complex assay, all cell lines showed a marked depletion of intracellular reduced folates, compared with those in standard folate medium. The monitoring of FBP by MOv18 showed on IGROVI cells a transient up-regulation of the protein, whereas on the other cell lines, except SKOV3, no changes were detected. These data suggest that in these cells further over-expression of the molecule cannot generally be induced by lowering the extracellular folate concentration. On SKOV3, Scatchard analysis of 125I-MOv18 binding, as well as the evaluation of total folate binding capacity, showed a 2- to 3-fold stable increase of FBP expression after long-term growth in low-folate medium. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis indicated in these cells a 1.5-fold increase in α-FBP mRNA. SKOV3 cells, maintained in vitro in medium containing supra-physiological and physiological (i.e., low-folate) concentrations were injected into nude mice. Weight differences, though not statistically significant, were observed in favour of low-folate-derived tumors. Immunohistochemical and immunochemical analysis of the tumor samples showed that in SKOV3 cells the receptor modulation can also be induced by restoring the physiological folate concentration in vivo.Keywords
This publication has 18 references indexed in Scilit:
- Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies MOv18 and MOv19European Journal Of Cancer, 1994
- Altered folate-binding protein mRNA stability in KB cells grown in folate-deficient mediumBiochemical Pharmacology, 1993
- Stable transfectants of human MCF-7 breast cancer cells with increased levels of the human folate receptor exhibit an increased sensitivity to antifolates.Journal of Clinical Investigation, 1993
- Isolation and biochemical characterization of the soluble and membrane forms of folate binding protein expressed in the ovarian carcinoma cell line IGROV1FEBS Letters, 1993
- Pharmacokinetics of Leucovorin Metabolites in Human Plasma as a Function of Dose Administrated Orally and IntravenouslyJNCI Journal of the National Cancer Institute, 1991
- Comparative Immunohistochemical Study of Four Monoclonal Antibodies Directed Against Ovarian Carcinoma-Associated AntigensInternational Journal of Gynecological Pathology, 1991
- The Ca-MOv18 molecule, a cell-surface marker of human ovarian carcinomas, is anchored to the cell membrane by phosphatidylinositolBiochemical and Biophysical Research Communications, 1990
- Folate-Binding ProteinsAnnual Review of Nutrition, 1990
- Characterization of human ovarian carcinoma‐associated antigens defined by novel monoclonal antibodies with tumor‐restricted specificityInternational Journal of Cancer, 1987
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976